Wuhan BJM Pharm Inc.
Contact:Linda Wang
Phone: 18607102166
Tel: 86-27-50661279
Fax: 86-27-87569543
Mail: sales04@benjaminpharmchem.com
Main product: UVT-150/OCTOCRYLENE/UV3039/Pirfenidone,Letrozole,IPTG,DL-Homocysteinethiolactone hydrochloride,Tris Base,Cyclopropylboronic Acid,L-Carnosine,L-Cysteine,D(+)-Tryptophan,BP-6,UV-3035,,Zinc pyrithione
2YR Audited Suppliers
Home
Product categories
Company Profile
Contacts
Home > Company Profile
Company Profile  Info marked by "" is verified
Name:Wuhan BJM Pharm Inc.
Category:Corporation/Limited Liability Company
Trade Category: Manufacturer
Legal Representative:Guifeng Zhu
Employees:11 - 50 People
Address:No .41 Optics Valley Avenue, East Lake High-tech D
Website:http://www.benjaminpharmchem.com/
Product/Service:UVT-150/OCTOCRYLENE/UV3039/Pirfenidone,Letrozole,IPTG,DL-Homocysteinethiolactone hydrochloride,Tris Base,Cyclopropylboronic Acid,L-Carnosine,L-Cysteine,D(+)-Tryptophan,BP-6,UV-3035,,Zinc pyrithione

Wuhan BJM Pharm Inc.


Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016,  obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate(DL-HOMO). At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd,  and the new production base settled in Geputan chemical park with  a total area of 50000 square meters.

We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends